Profile data is unavailable for this security.
About the company
Nanjing King-friend Biochemical Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production, and sales of drugs. The Company's main products include cardiovascular, neurological, anesthetic, anti-tumor preparations, surgical auxiliary and other high-value-added sterile injections. The Company's main businesses include: sterile injection business, heparin API business, pharmaceutical contract research and development and production organization (CDMO) business, and biopharmaceutical innovation business.
- Revenue in CNY (TTM)3.76bn
- Net income in CNY649.83m
- Incorporated2000
- Employees1.36k
- LocationNanjing King-friend Biochemical Pharmaceutical Co LtdNo. 16 Xuefu RoadHigh-tech Industrial Development ZoneNANJING 210061ChinaCHN
- Phone+86 2 586990789
- Fax+86 2 586990701
- Websitehttps://www.nkf-pharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Haoyuan Chemexpress Co Ltd | 2.71bn | 294.90m | 14.95bn | 3.58k | 50.51 | 4.80 | -- | 5.52 | 1.40 | 1.40 | 12.85 | 14.67 | 0.504 | 1.10 | 3.98 | 757,880.40 | 5.37 | 5.94 | 7.32 | 7.80 | 48.93 | 45.09 | 10.66 | 11.74 | 1.46 | 7.54 | 0.4102 | 16.95 | 20.75 | 40.89 | 58.17 | 22.38 | 71.42 | -- |
| Zhejiang Medicine Co Ltd | 8.96bn | 1.24bn | 15.41bn | 5.82k | 12.39 | 1.39 | -- | 1.72 | 1.29 | 1.29 | 9.31 | 11.50 | 0.6499 | 2.76 | 5.65 | 1,540,449.00 | 8.19 | 5.31 | 10.15 | 6.93 | 39.47 | 36.97 | 12.60 | 7.68 | 2.01 | -- | 0.0784 | 30.91 | 20.29 | 5.88 | 170.11 | 27.62 | 3.74 | -18.03 |
| Zhejiang Jiuzhou Pharmaceutical Co Ltd | 5.36bn | 722.87m | 15.61bn | 5.00k | 21.63 | 1.78 | -- | 2.91 | 0.8113 | 0.8113 | 6.07 | 9.84 | 0.493 | 1.97 | 4.84 | 1,070,948.00 | 6.65 | 9.23 | 7.91 | 12.19 | 34.65 | 33.78 | 13.50 | 15.64 | 2.42 | -- | 0.0152 | 39.55 | -6.57 | 20.67 | -41.34 | 20.58 | 22.64 | 8.45 |
| China Resources Jingzhng Phrmctcl Co Ltd | 4.40bn | 837.30m | 15.85bn | 4.18k | 18.88 | 4.18 | -- | 3.60 | 1.32 | 1.32 | 6.94 | 5.98 | 0.6755 | 3.53 | 11.30 | 1,051,350.00 | 14.12 | 11.45 | 23.31 | 16.72 | 60.96 | 64.04 | 20.91 | 18.23 | 1.33 | -- | 0.0348 | 93.25 | -2.59 | 12.61 | 9.67 | 11.20 | 30.67 | 36.85 |
| Nanjing King-Frind Bchmcl Phrmctcl C Ltd | 3.76bn | 649.83m | 15.88bn | 1.36k | 24.10 | 2.35 | -- | 4.22 | 0.4079 | 0.4079 | 2.35 | 4.18 | 0.3812 | 0.6322 | 3.82 | 2,765,677.00 | 6.59 | 8.38 | 8.99 | 12.03 | 41.12 | 44.95 | 17.28 | 19.72 | 1.35 | -- | 0.2644 | 23.22 | -0.1984 | 9.70 | 536.09 | 6.43 | 34.44 | -6.04 |
| Guobang Pharma Ltd | 5.94bn | 872.95m | 15.96bn | 4.00k | 18.19 | 1.93 | -- | 2.69 | 1.57 | 1.57 | 10.68 | 14.80 | 0.5603 | 3.06 | 7.04 | 1,484,531.00 | 8.20 | 9.52 | 10.33 | 12.47 | 24.67 | 27.10 | 14.64 | 14.91 | 2.30 | -- | 0.1038 | 24.76 | 10.12 | 9.15 | 27.61 | 19.94 | -7.08 | -- |
| Tonghua Dongbao Pharmaceutical Co Ltd | 2.74bn | 1.23bn | 17.04bn | 3.41k | 13.87 | 2.39 | -- | 6.22 | 0.6271 | 0.6271 | 1.40 | 3.64 | 0.3589 | 1.05 | 5.11 | 803,924.60 | 15.84 | 14.89 | 17.08 | 15.68 | 71.05 | 78.86 | 44.15 | 35.26 | 3.49 | -- | 0.0988 | 50.60 | -34.66 | -6.27 | -103.66 | -- | 14.17 | 4.56 |
Data as of Feb 13 2026. Currency figures normalised to Nanjing King-friend Biochemical Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
7.76%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 47.87m | 2.97% |
| Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Jun 2025 | 34.27m | 2.12% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 11.59m | 0.72% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 7.18m | 0.45% |
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2025 | 7.00m | 0.43% |
| Franklin Templeton Sealand Fund Management Co., Ltd.as of 30 Jun 2025 | 4.81m | 0.30% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 4.32m | 0.27% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 3.90m | 0.24% |
| Cinda Fund Management Co. Ltd.as of 30 Jun 2025 | 2.45m | 0.15% |
| Aegon-Industrial Fund Management Co., Ltd.as of 30 Jun 2025 | 1.90m | 0.12% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
